DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Diphenoxylate Hydrochloride W/ Atropine Sulfate patents expire, and what generic alternatives are available?
Diphenoxylate Hydrochloride W/ Atropine Sulfate is a drug marketed by Scherer Rp and is included in one NDA.
The generic ingredient in DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE?
- What are the global sales for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE?
- What is Average Wholesale Price for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE?
Summary for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 1 |
| Patent Applications: | 60 |
| DailyMed Link: | DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE at DailyMed |
Recent Clinical Trials for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 2 |
| Puma Biotechnology, Inc. | Phase 2 |
| Napo Pharmaceuticals, Inc. | Phase 2 |
See all DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE clinical trials
US Patents and Regulatory Information for DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scherer Rp | DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE | atropine sulfate; diphenoxylate hydrochloride | CAPSULE;ORAL | 086440-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
